Idexx Laboratories (IDXX) Income from Non-Controlling Interests (2010 - 2021)
Idexx Laboratories (IDXX) posted quarterly Income from Non-Controlling Interests of -$57000.0 for Q3 2021, down 155.88% year-over-year from $102000.0 in Q3 2020, and down 337.5% on a QoQ basis from $24000.0 in Q2 2021.
Idexx Laboratories (IDXX) Income from Non-Controlling Interests (2010 - 2021) Analysis & Trends
Idexx Laboratories (IDXX) has reported Income from Non-Controlling Interests for 12 consecutive years, with -$57000.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Income from Non-Controlling Interests fell 155.88% year-over-year to -$57000.0; the TTM figure through Jun 2022 stood at -$57000.0 (down 117.48% YoY), while the FY2021 annual figure was -$1000.0, down 100.28% from the prior year.
- Income from Non-Controlling Interests came in at -$57000.0 for Q3 2021 at Idexx Laboratories, down from $24000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $168000.0 in Q4 2020, with the low at -$57000.0 in Q3 2021.
- Average Income from Non-Controlling Interests over 5 years is $29842.1, with a median of $29000.0 recorded in 2020.
- Across the five-year window, Income from Non-Controlling Interests sank 1333.33% in 2018 and jumped 10100.0% in 2020, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $33000.0 in 2017, then advanced by 18.18% to $39000.0 in 2018, then rose by 23.08% to $48000.0 in 2019, then surged by 250.0% to $168000.0 in 2020, then plunged by 133.93% to -$57000.0 in 2021.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered -$57000.0, $24000.0, and $32000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -57,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 32,000.00 |
| Dec 31, 2020 | 168,000.00 |
| Sep 30, 2020 | 102,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | 29,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | 1,000.00 |
| Jun 30, 2019 | -5,000.00 |
| Mar 31, 2019 | 28,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | -37,000.00 |
| Jun 30, 2018 | -11,000.00 |
| Mar 31, 2018 | 25,000.00 |
| Dec 31, 2017 | 33,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 39,000.00 |
| Dec 31, 2016 | 2,000.00 |